Immunotherapies
have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News

Congrats to @oNKo_innate: Emerging Company of the Year at the 2021 #AusBiotech & @JNJInnovation Industry Excellence Awards. Dedicated to how the immune system may be better harnessed to treat cancer, it is a true exemplar of a uni-industry partnership success. @connell_kathy

Load More...
 
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
OUR APPROACH
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
lab1-webRes
o o
o
THE TEAM
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are